← Leaderboards
Eric M Rosenberg
Yale University
$87,717
Attributed
$87,717
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $29.7K · FY2017–19$50K$37.5K$25K$12.5K$0
'17
'18
'19
Funding mix
By agency
NIH$87,717 · 1
By mechanism
F31$87,717 · 1
Top collaborators
No co-investigators on record.
Most similar at Yale University
Same institution · by research overlap
- Neil David Romberg$5,397,173
- Liang Shan$9,720,717
- Nancy H Ruddle$6,951,769
- Joao Pereira$7,152,978
- Elias Lolis$7,866,115
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectCharacteristicsAllelesAntibody AffinityAgonistAdaptive ImmunityAutocrineAutoimmune DiseasesBasic ScienceB-Cell ActivationBindingBinding ProteinsBiological Response Modifier TherapyBloodBlr1 GeneB-LymphocytesBreedingCd4 Positive T LymphocytesCell LineCell MaturationCell ProliferationCellsCell SurvivalChemokine
Grant awards (3)
Elucidating the role of the CXCL13/CXCR5 signaling axis in Angioimmunoblastic T-Cell Lymphoma (AITL)$29,727
F31 · FY2019 · CA · contact PI
Elucidating the role of the CXCL13/CXCR5 signaling axis in Angioimmunoblastic T-Cell Lymphoma (AITL)$29,235
F31 · FY2018 · CA · contact PI
Elucidating the role of the CXCL13/CXCR5 signaling axis in Angioimmunoblastic T-Cell Lymphoma (AITL)$28,755
F31 · FY2017 · CA · contact PI